News Home

Should Biotechnology Stock Polarityte Inc (PTE) Be in Your Portfolio Monday?

Monday, May 16, 2022 01:41 PM | InvestorsObserver Analysts
Should Biotechnology Stock Polarityte Inc (PTE) Be in Your Portfolio Monday?

Polarityte Inc (PTE) is near the top in its industry group according to InvestorsObserver. PTE gets an overall rating of 61. That means it scores higher than 61 percent of stocks. Polarityte Inc gets a 84 rank in the Biotechnology industry. Biotechnology is number 68 out of 148 industries.

Overall Score - 61
PTE has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on PTE!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Polarityte Inc Stock Today?

Polarityte Inc (PTE) stock is lower by -14.93% while the S&P 500 has gained 0.17% as of 1:40 PM on Monday, May 16. PTE is down -$0.03 from the previous closing price of $0.21 on volume of 6,258,920 shares. Over the past year the S&P 500 is down -3.18% while PTE is down -80.22%. PTE lost -$0.38 per share the over the last 12 months. Click Here to get the full Stock Report for Polarityte Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App